MedPath

Triangle Pharmaceuticals

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

8

Active:0
Completed:4

Trial Phases

3 Phases

Phase 2:4
Phase 3:3
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials

Phase 2
4 (50.0%)
Phase 3
3 (37.5%)
Not Applicable
1 (12.5%)

A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.

Phase 2
Conditions
Hepatitis B
First Posted Date
2002-08-21
Last Posted Date
2005-06-24
Lead Sponsor
Triangle Pharmaceuticals
Target Recruit Count
30
Registration Number
NCT00044135
Locations
🇺🇸

University of Illinois at Chicago, Chicago, Illinois, United States

🇺🇸

Thomas Jefferson University Hospital, Jefferson Medical College, Philadelphia, Pennsylvania, United States

🇨🇦

Viridae, Vancouver, Canada

and more 8 locations

Comparing FTC and Lamivudine in HIV-Infected Patients on a Stable Anti-HIV Drug Combination

Phase 3
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2005-06-24
Lead Sponsor
Triangle Pharmaceuticals
Target Recruit Count
390
Registration Number
NCT00002416
Locations
🇺🇸

Dr Robert Wallace, St. Petersburg, Florida, United States

🇺🇸

North Shore Univ Hosp, Great Neck, New York, United States

A Randomized, Double-Blind Study of MKC-442 Combined With Viracept in Patients Who Are Epivir + Retrovir Experienced and Are Protease Inhibitor- and Non-Nucleoside Reverse Transcriptase Inhibitor-Naive

Not Applicable
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2005-06-24
Lead Sponsor
Triangle Pharmaceuticals
Registration Number
NCT00002215
Locations
🇺🇸

Anderson Clinical Research, Pittsburgh, Pennsylvania, United States

A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Phase 3
Suspended
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2005-06-24
Lead Sponsor
Triangle Pharmaceuticals
Registration Number
NCT00002362
Locations
🇺🇸

Ctr for AIDS Research / Education and Service (CARES), Sacramento, California, United States

🇺🇸

San Francisco Veterans Administration Med Ctr, San Francisco, California, United States

🇺🇸

Gary Richmond MD, Fort Lauderdale, Florida, United States

and more 7 locations

Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIV

Phase 2
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2005-06-24
Lead Sponsor
Triangle Pharmaceuticals
Target Recruit Count
100
Registration Number
NCT00017992
Locations
🇺🇸

USC School of Medicine / LA County Med Ctr, Los Angeles, California, United States

🇺🇸

Univ of Florida Health Science Ctr / Pediatrics, Jacksonville, Florida, United States

🇺🇸

Univ of Miami, Miami, Florida, United States

and more 11 locations
  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.